Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
IMAGe syndrome is characterized by the association of intrauterine growth retardation, metaphyseal dysplasia (and short limbs), adrenal hypoplasia congenita, and genital anomalies. It has been described in less than 20 cases. The patients also present with dysmorphic features (frontal bossing, broad nasal bridge, low-set ears). In boys, genital anomalies include bilateral cryptorchidism, hypospadias, micropenis, and hypogonadotropic hypogonadism. This syndrome is likely to be transmitted as an autosomal recessive trait.
Features include always present findings: Short nose, Prominent forehead, Mild bone density loss (osteopenia), and Adrenal hypoplasia and others; and very common findings: Delayed skeletal maturation, Hypercalciuria, and Metaphyseal dysplasia. 20 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Growth and development | 3 | Decreased response to growth hormone stimulation test, Postnatal growth retardation, Intrauterine growth retardation |
Head and neck | 2 | Craniosynostosis, Macrocephaly |
Bones and joints | 2 | Delayed skeletal maturation, Mild bone density loss (osteopenia) |
Brain and nerves | 2 | Global developmental delay, Depressed nasal bridge |
Hormones | 2 | Adrenal hypoplasia, Decreased response to growth hormone stimulation test |
Age of onset: at birth.
Thirty-one individuals reported from 19 families have features consistent with the clinical diagnosis of IMAGe syndrome [, , , , , , , , , , , , , , ]. Of these 31 individuals, 19 from eleven unrelated families have had the diagnosis confirmed molecularly . Of the twelve individuals who have not had confirmatory genetic testing, nearly all have clinical findings that significantly overlap those of the individuals with a molecularly confirmed diagnosis. A diagnosis of IMAGe syndrome has been considered in other published cases; however, the clinical information was either significantly different from the 31 typical cases or insufficient to determine the diagnosis with certainty, and pathogenic CDKN1C variants were not reported [, , , , , ]. Several of these cases are further discussed in .
Source: GeneReviews — "IMAGe Syndrome"
CDKN1C encodes cyclin dependent kinase inhibitor 1C (316 aa). Potent tight-binding inhibitor of several G1 cyclin/CDK complexes (cyclin E-CDK2, cyclin D2-CDK4, and cyclin A-CDK2) and, to lesser extent, of the mitotic cyclin B-CDC2.
IMAGe syndrome is associated with mutations in the CDKN1C gene on chromosome 11.
The CDKN1C protein participates in CDK4,CDK6:CCND:CDKN1A,CDKN1B,(CDKN1C); CDK4,CDK6:CCND; (CDK4,CDK6:CCND:p-Y88-CDKN1B), p-T172-CDK4,p-T177-CDK6:CCND:CDKN1A,CDKN1B,(CDKN1C); p-T172-CDK4,p-T177-CDK6:CCND; (p-T172-CDK4,p-T177-CDK6:CCND:p-Y88-CDKN1B), and Cyclin D:CDK4,CDK6:CDKN1A,CDKN1B,(CDKN1C) pathways.
CDKN1C is classified as a druggable target (Clinically Actionable and Kinase categories) with score 11.6.
Currently, no genotype-phenotype correlations are known.
Source: GeneReviews — "IMAGe Syndrome"
Although few large pedigrees with IMAGe syndrome have been reported to date, it is clear that the mode of inheritance is autosomal dominant in which only maternal transmission of the imprinted pathogenic variant results in IMAGe syndrome . In one large family of 24 individuals, all seven individuals with IMAGe syndrome inherited the CDKN1C pathogenic variant from their mother. Consistent with the imprinted expression of CDKN1C, unaffected individuals either inherited the pathogenic variant from their father (n=9) or did not have the pathogenic variant (n=8) .
Source: GeneReviews — "IMAGe Syndrome"
IMAGe syndrome is an acronym for the major findings in this disorder: intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genitourinary abnormalities (in males) . No formal clinical diagnostic criteria for IMAGe syndrome have been defined.
IMAGe syndrome should be suspected in individuals with the following clinical, imaging, and suggestive laboratory findings.
Clinical findings
Source: GeneReviews — "IMAGe Syndrome"
Adrenal Insufficiency
Table 2.
Disorders with Adrenal Insufficiency in the Differential Diagnosis of IMAGe Syndrome
Gene(s) / Genetic Mechanism | DiffDx Disorder | MOI | Clinical Features of DiffDx Disorder
Overlapping w/IMAGe Syndrome | Distinguishing from IMAGe Syndrome
CYP11B1
CYP17A1
CYP21A2
| Congenital adrenal hyperplasia resulting from: 11-beta hydroxylase deficiency (OMIM 202010); 17-alpha hydroxylase deficiency (OMIM 202110); 21-hydroxylase-deficiency; or 3-beta hydroxysteroid dehydrogenase deficiency (OMIM 201810) | AR | Ambiguous genitalia at birth, adrenal crisis in infancy or childhood | • Infants w/CAH rarely have IUGR.
Source: GeneReviews — "IMAGe Syndrome"
Genetic testing for CDKN1C is available. Testing is considered confirmatory for diagnosis.
No approved treatments are currently available for IMAGe syndrome. The disease remains an area of unmet medical need.
Evaluations Following Initial Diagnosis To establish the extent of disease and needs in an individual diagnosed with IMAGe syndrome, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended. Table 4. Recommended Evaluations Following Initial Diagnosis in Individuals with IMAGe Syndrome
System/Concern | Evaluation | Comment |
|---|---|---|
Genitourinary | Urogenital eval consultation w/urologist | To determine mgmt of undescended testicles /or genital surgery |
Musculoskeletal | Clinical orthopedic assessment for hip dysplasia /or scoliosis | Developmental |
assessment | Assess for delays assoc w/hypotonia /or other developmental concerns | Genetic |
counseling | By genetics professionals1 | To inform patients their families re nature, MOI, implications of IMAGe syndrome in order to facilitate medical personal decision making Family support resources |
Source: GeneReviews — "IMAGe Syndrome"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "IMAGe Syndrome"
1 trial found
Table 5. Recommended Surveillance for Individuals with IMAGe Syndrome
System/Concern | Evaluation | Frequency |
|---|---|---|
Growth | Measurement of growth parameters | At each visit |
Endocrine | Endocrinologist evals for adrenal insufficiency potentially for hypercalciuria nephrocalcinosis | Annually more often as needed Skeletal |
complications | Orthopedist eval to monitor scoliosis, tibial/femoral bowing, or pain assoc w/skeletal dysplasia | As needed Development |
Source: GeneReviews — "IMAGe Syndrome"
Phenotype severity distribution: 5 always present features, 3 very common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
5 publications have been identified in PubMed for IMAGe syndrome. Research spans Case Report / Case Series (60%), Review / Meta-Analysis (20%), and Basic Science / Preclinical (20%).
Parretta S (2026). [PMID: 42074571](https://pubmed.ncbi.nlm.nih.gov/42074571/). *Genes (Basel)*. [Review / Meta-Analysis]
Dalili S (2025). [PMID: 41218602](https://pubmed.ncbi.nlm.nih.gov/41218602/). *Molecular genetics & genomic medicine*. [Case Report / Case Series]
Vimercati A (2025). [PMID: 39412159](https://pubmed.ncbi.nlm.nih.gov/39412159/). *The Journal of clinical endocrinology and metabolism*. [Basic Science / Preclinical]
Horvit A (2025). [PMID: 40496473](https://pubmed.ncbi.nlm.nih.gov/40496473/). *JCEM case reports*. [Case Report / Case Series]
Luo N (2024). [PMID: 38965965](https://pubmed.ncbi.nlm.nih.gov/38965965/). *Clinical laboratory*. [Case Report / Case Series]
Data assembled from 8 of 12 sources · Last updated Sep 20, 2026, 1:11 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about IMAGe syndrome